Most Active Series C Investors in Switzerland
71 Series C rounds · €2.3 billion invested
StageSeries C · locked
Year
Sector
Show
71
Total Rounds
€2.3 billion
Total Volume
€33.9 million
Avg Deal Size
83%
Rounds w/ Investors
Switzerland saw 71 funding rounds across all tracked years, totalling €2.3 billion. Seed was the most active stage. 83% of rounds disclosed their investors.
Deal Count by Stage
Top 20 Series C Investors in Switzerland
| # | ||
|---|---|---|
| 1 | VI Partners | 5 |
| 2 | Swisscom Ventures | 5 |
| 3 | Verve Ventures | 3 |
| 4 | Ysios Capital | 3 |
| 5 | Novartis Venture Fund | 2 |
| 6 | Emerald Technology Ventures | 2 |
| 7 | Taiwania Capital | 2 |
| 8 | MP Healthcare Venture Management | 2 |
| 9 | SwissCanto | 2 |
| 10 | BioMed Partners | 2 |
| 11 | EntrePREneurs Fund | 2 |
| 12 | NeoMed | 2 |
| 13 | Life Sciences Partners | 2 |
| 14 | Future Industry Ventures | 2 |
| 15 | Atila Venture | 1 |
| 16 | Aster Capital | 1 |
| 17 | Alibaba | 1 |
| 18 | Armira Growth | 1 |
| 19 | Aravis Ventures | 1 |
| 20 | Alantra | 1 |
Other Stages in Switzerland
Also see:
About Series C Investing in Switzerland
Switzerland's Series C ecosystem is tracked by CAPLINK. The table above ranks investors by the number of Series C rounds they participated in. Series C investors funding expansion and market leadership rounds.
Use the year and sector filters above to narrow down the ranking. To explore other funding stages in Switzerland, use the stage navigation pills above.